9 August 2017

In the project 'From animal model to translational strategy' funded by NWO (NWO_313-99-310) the aim is to evaluate how translation from animal models to the human clinic can be improved. Partners in the project are Utrecht University, SYRCLE and the firm ProQR.

From SYRCLE, Cathalijn Leenaars, Rob de Vries and Merel Ritskes-Hoitinga participate in this project.Through systematic reviews we wish to identify success factors for a better translation from animal to human. One of the systematic reviews focuses on rheumatoid arthritis, and we work closely together with the patient organization ReumaZorg Nederland (RZN). The input from patients in our research project is relevant and rewarding.
As a result of this cooperation, Merel has been asked to participate in the medical advisory council of RZN, to advise on matters related to animal studies in health care research

Photo of participants of a valorization meeting, NWO project, Utrecht, January 2017

Related news items


Dutch Cancer Society Grant received by Annemiek van Spriel and Laia Querol-Cano

23 September 2020

Annemiek van Spriel and Laia Querol-Cano received a Dutch Cancer Society Grant of 707,298 euros to study the cancer cell surface in immunotherapy.

read more

Frank Walboomers 25-years work anniversary at Radboudumc

17 September 2020

Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.

read more

Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes

17 September 2020

Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.

read more

Annette Schenck appointed professor of Translational Genetics

17 September 2020

Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.

read more

Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients

17 September 2020

Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.

read more